Tiantan Biopharma postpones 2024 annual general meeting
Beijing Tiantan Biological Products Corp (SSE:600161) announced the postponement of its 2024 Annual General Meeting of Shareholders, originally scheduled for May 20, 2025, to May 27, 2025. The company cited a scheduling conflict that prevents several directors from attending the original date. The record date for shareholders eligible to attend the meeting remains unchanged at May 13, 2025. The meeting will still be held at 13:30 on May 27, 2025, and online voting will be available on the same day.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Beijing Tiantan Biological Products Corp publishes news
Free account required • Unsubscribe anytime